Cameron Snell

3.0k citations

44 papers · 1.9k indexed · h-index 18

Impact in

Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology top 10%
- Angiogenesis and VEGF in Cancer
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Circular RNAs in diseases

Papers in ⓘ

Oncology 22
- HER2/EGFR in Cancer Research 7
- Cytokine Signaling Pathways and Interactions 3
Molecular Biology 19
- Angiogenesis and VEGF in Cancer 4
- Fibroblast Growth Factor Research 4

Co-authors: Adrian L. Harris (11 shared papers)Helen Turley (5 shared papers)Jiliang Li (4 shared papers)Francesca M. Buffa (3 shared papers)Alan McIntyre (4 shared papers)Kevin C. Gatter (4 shared papers)Helen Sheldon (3 shared papers)Francesco Pezzella (3 shared papers)
Journals: Cancer Research (3 papers)Clinical Cancer Research (2 papers)Breast Cancer Research (2 papers)Cancers (2 papers)Modern Pathology (2 papers)
Partner nations: Australia United Kingdom Canada

In The Last Decade

Cameron Snell

41 papers receiving 1.9k citations

Peers

Countries citing papers authored by Cameron Snell

Since Specialization

Citations

This map shows the geographic impact of Cameron Snell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron Snell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron Snell more than expected).

Fields of papers citing papers by Cameron Snell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cameron Snell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron Snell. The network helps show where Cameron Snell may publish in the future.

Co-authors

The 25 scholars most cited alongside Cameron Snell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cameron Snell Line = papers co-authored together Cameron Snell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Glucose Utilization via Glycogen Phosphorylase Sustains Proliferation and Prevents Premature Senescence in Cancer Cells Cell Metabolism ·Elena Favaro, Karim Bensaad, Mei Chong, Daniel A. Tennant, David Ferguson, Cameron Snell, Graham Steers, Helen Turley, Jiliang Li, Ulrich L. Günther, Francesca M. Buffa, Alan McIntyre, Adrian L. Harris	2012	305
2	microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer Cancer Research ·Francesca M. Buffa, Carlos Camps, Laura Winchester, Cameron Snell, Harriet E. Gee, Helen Sheldon, Marian Taylor, Adrian L. Harris, Jiannis Ragoussis	2011	251
3	Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment? Cancer Medicine ·Tom Dønnem, Jiangting Hu, Mary Ferguson, Omanma Adighibe, Cameron Snell, Adrian L. Harris, Kevin C. Gatter, Francesco Pezzella	2013	202
4	Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy Clinical Cancer Research ·Alan McIntyre, Shalini Patiar, Simon Wigfield, Jiliang Li, Ioanna Ledaki, Helen Turley, Russell Leek, Cameron Snell, Kevin C. Gatter, William S. Sly, Richard D. Vaughan‐Jones, Pawel Swietach, Adrian L. Harris	2012	188
5	DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo Cancer Research ·Jiliang Li, Richard C.A. Sainson, Chern Ein Oon, Helen Turley, Russell Leek, Helen Sheldon, Esther Bridges, Wen Shi, Cameron Snell, Emma T. Bowden, Herren Wu, Partha S. Chowdhury, Angela J. Russell, Craig P. Montgomery, Richard Poulsom, Adrian L. Harris	2011	187
6	BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1tumour phenotype Breast Cancer Research ·Cameron Snell, Michael Krypuy, Ee Ming Wong, (unknown), Maurice B. Loughrey, Alexander Dobrovic	2008	100
7	Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor Growth Cancer Research ·Alan McIntyre, Alžbeta Hulı́ková, Ioanna Ledaki, Cameron Snell, Dean C. Singleton, Graham Steers, Peter Seden, Dylan T. Jones, Esther Bridges, Simon Wigfield, Jiliang Li, Angela J. Russell, Pawel Swietach, Adrian L. Harris	2016	77
8	Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination Proceedings of the National Academy of Sciences ·Ben Emery, Holly S. Cate, Mark Marriott, Tobias D. Merson, Michele D. Binder, Cameron Snell, Pik Ying Soo, Simon S. Murray, Ben A. Croker, Jian‐Guo Zhang, Warren S. Alexander, Helen Cooper, Helmut Butzkueven, Trevor J. Kilpatrick	2006	69
9	Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer Journal of Thoracic Oncology ·Mark N. Adams, Joshua T. Burgess, Yaowu He, Kathy Gately, Cameron Snell, Shudong Zhang, John D. Hooper, Derek J. Richard, Kenneth J. O’Byrne	2017	63
10	PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer Oncogene ·S-J Fan, Cameron Snell, Helen Turley, JL Li, R McCormick, Sumeth Perera, Sabine Heublein, Shubana Kazi, Abul Kalam Azad, Clive Wilson, Adrian L. Harris, Deborah C. I. Goberdhan	2015	50
11	EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2 Blood ·Alexandre S. Cristino, Jamie P. Nourse, Rachael A. West, Muhammed B. Sabdia, Soi Cheng Law, Jay Gunawardana, Frank Vari, Sally Mujaj, Gayathri Thillaiyampalam, Cameron Snell, Madeline Gough, Colm Keane, Maher K. Gandhi	2019	50
12	CSF1R-dependent macrophages control postnatal somatic growth and organ maturation PLoS Genetics ·Sahar Keshvari, Melanie Caruso, Ngari Teakle, Lena Batoon, Anuj Sehgal, Omkar L. Patkar, Michelle Ferrari-Cestari, Cameron Snell, Chen Chen, Alexander J. Stevenson, Felicity M. Davis, Stephen J. Bush, Clare Pridans, Kim Summers, Allison R. Pettit, Katharine M. Irvine, David Hume	2021	49
13	Proline-Hydroxylated Hypoxia-Inducible Factor 1α (HIF-1α) Upregulation in Human Tumours PLoS ONE ·Cameron Snell, Helen Turley, Alan McIntyre, Demin Li, Massimo Masiero, Christopher J. Schofield, Kevin C. Gatter, Adrian L. Harris, Francesco Pezzella	2014	42
14	Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients Leukemia ·Kah Keng Wong, Duncan M. Gascoyne, P. Brown, Elizabeth J. Soilleux, Cameron Snell, H Chen, Linden Lyne, Charles H. Lawrie, Randy D. Gascoyne, Lars Møller Pedersen, Michael Møller, Karen Pulford, Derek Murphy, T M Green, Alison H. Banham	2013	27
15	SOCS3 negatively regulates LIF signaling in neural precursor cells Molecular and Cellular Neuroscience ·Ben Emery, Tobias D. Merson, Cameron Snell, Kaylene M. Young, Matthias Ernst, Trevor J. Kilpatrick	2006	24
16	The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer Breast Cancer Research and Treatment ·Romain Tropée, Bárbara de la Peña Avalos, Madeline Gough, Cameron Snell, Pascal H. G. Duijf, Eloïse Dray	2020	19
17	Heparanase Promotes Syndecan-1 Expression to Mediate Fibrillar Collagen and Mammographic Density in Human Breast Tissue Cultured ex vivo Frontiers in Cell and Developmental Biology ·Xuan Huang, Gina Reye, Konstantin I. Momot, Tony Blick, Thomas Lloyd, Wayne D. Tilley, Theresa E. Hickey, Cameron Snell, Rachel K. Okolicsanyi, Larisa M. Haupt, Vito Ferro, Erik W. Thompson, Honor J. Hugo	2020	17
18	Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine Molecular Oncology ·Zay Yar Oo, Martina Proctor, Alexander J. Stevenson, Deborah Nazareth, Madushan Fernando, Sheena M. Daignault, Catherine Lanagan, Sebastian Walpole, Vanessa Bonazzi, Dubravka Škalamera, Cameron Snell, Nikolas K. Haass, Jill E. Larsen, Brian Gabrielli	2019	17
19	FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes Clinical Cancer Research ·Asmerom T. Sengal, Ann‐Marie Patch, Cameron Snell, Deborah S. Smith, Samuel Leung, Aline Talhouk, Elizabeth D. Williams, Jessica N. McAlpine, Pamela M. Pollock	2020	14
20	Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer—insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system Breast Cancer Research ·Razan Wafai, Elizabeth D. Williams, Emma de Souza, Peter T. Simpson, Amy E. McCart Reed, Jamie R. Kutasovic, Mark Waltham, Cameron Snell, Tony Blick, Erik W. Thompson, Honor J. Hugo	2020	14

About Cameron Snell

Cameron Snell is a scholar working on Oncology, Molecular Biology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 44 papers that have together received 1.9k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), Breast Cancer Treatment Studies (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Fibroblast Growth Factor Research (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). The work is most often cited by research in Cancer Research (787 citations), Molecular Biology (1.3k citations), Oncology (482 citations), Immunology (212 citations) and Genetics (104 citations). Cameron Snell has collaborated with scholars based in Australia, United Kingdom and Canada. Frequent co-authors include Adrian L. Harris, Helen Turley, Jiliang Li, Francesca M. Buffa, Alan McIntyre, Kevin C. Gatter, Helen Sheldon, Francesco Pezzella, Graham Steers and Harriet E. Gee. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Breast Cancer Research, Cancers and Modern Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact